New drug targets rare Cancer's genetic weakness
Disease control
Recruiting now
This study tests a new drug called REM-422 in people with advanced adenoid cystic carcinoma (ACC), a rare cancer of the glands. The drug works by breaking down a specific genetic message (MYB mRNA) that helps the cancer grow. The trial will enroll 125 participants to see if the d…
Phase: PHASE1, PHASE2 • Sponsor: Remix Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC